What Does RSVIG Stand For?

RSVIG stands for Respiratory Synctial Virus Immune Globulin

RSVIG, or Respiratory Syncytial Virus Immune Globulin, is a specialized immunoglobulin preparation used for the prevention and treatment of respiratory syncytial virus (RSV) infections, particularly in high-risk infants and young children. It contains antibodies that help enhance the immune response against RSV, reducing the severity and incidence of the disease. RSVIG is administered via intravenous infusion and is a critical therapeutic option for managing RSV-related complications in vulnerable populations.